Copyright Reports & Markets. All rights reserved.

Global Non-invasive Continuous Glucose Monitor Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Non-invasive Continuous Glucose Monitor Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Wristband Type
    • 1.3.3 Patch Type
    • 1.3.4 Others
  • 1.4 Market Analysis by Replacement Mechanism
    • 1.4.1 Overview: Global Non-invasive Continuous Glucose Monitor Consumption Value by Replacement Mechanism: 2021 Versus 2025 Versus 2032
    • 1.4.2 Replaceable Type
    • 1.4.3 Long-term Retention Type
  • 1.5 Market Analysis by Intelligence
    • 1.5.1 Overview: Global Non-invasive Continuous Glucose Monitor Consumption Value by Intelligence: 2021 Versus 2025 Versus 2032
    • 1.5.2 Basic Type
    • 1.5.3 Intelligent Type
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Non-invasive Continuous Glucose Monitor Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Hospital
    • 1.6.3 Clinic
    • 1.6.4 Other
  • 1.7 Global Non-invasive Continuous Glucose Monitor Market Size & Forecast
    • 1.7.1 Global Non-invasive Continuous Glucose Monitor Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Non-invasive Continuous Glucose Monitor Sales Quantity (2021-2032)
    • 1.7.3 Global Non-invasive Continuous Glucose Monitor Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Non-invasive Continuous Glucose Monitor Product and Services
    • 2.1.4 Roche Non-invasive Continuous Glucose Monitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Roche Recent Developments/Updates
  • 2.2 Abbott
    • 2.2.1 Abbott Details
    • 2.2.2 Abbott Major Business
    • 2.2.3 Abbott Non-invasive Continuous Glucose Monitor Product and Services
    • 2.2.4 Abbott Non-invasive Continuous Glucose Monitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Abbott Recent Developments/Updates
  • 2.3 Medtronic
    • 2.3.1 Medtronic Details
    • 2.3.2 Medtronic Major Business
    • 2.3.3 Medtronic Non-invasive Continuous Glucose Monitor Product and Services
    • 2.3.4 Medtronic Non-invasive Continuous Glucose Monitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Medtronic Recent Developments/Updates
  • 2.4 Dexcom
    • 2.4.1 Dexcom Details
    • 2.4.2 Dexcom Major Business
    • 2.4.3 Dexcom Non-invasive Continuous Glucose Monitor Product and Services
    • 2.4.4 Dexcom Non-invasive Continuous Glucose Monitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Dexcom Recent Developments/Updates
  • 2.5 I-SENS
    • 2.5.1 I-SENS Details
    • 2.5.2 I-SENS Major Business
    • 2.5.3 I-SENS Non-invasive Continuous Glucose Monitor Product and Services
    • 2.5.4 I-SENS Non-invasive Continuous Glucose Monitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 I-SENS Recent Developments/Updates
  • 2.6 77 Elektronika
    • 2.6.1 77 Elektronika Details
    • 2.6.2 77 Elektronika Major Business
    • 2.6.3 77 Elektronika Non-invasive Continuous Glucose Monitor Product and Services
    • 2.6.4 77 Elektronika Non-invasive Continuous Glucose Monitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 77 Elektronika Recent Developments/Updates
  • 2.7 Senseonics
    • 2.7.1 Senseonics Details
    • 2.7.2 Senseonics Major Business
    • 2.7.3 Senseonics Non-invasive Continuous Glucose Monitor Product and Services
    • 2.7.4 Senseonics Non-invasive Continuous Glucose Monitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Senseonics Recent Developments/Updates
  • 2.8 Yuwell
    • 2.8.1 Yuwell Details
    • 2.8.2 Yuwell Major Business
    • 2.8.3 Yuwell Non-invasive Continuous Glucose Monitor Product and Services
    • 2.8.4 Yuwell Non-invasive Continuous Glucose Monitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Yuwell Recent Developments/Updates
  • 2.9 Sinocare
    • 2.9.1 Sinocare Details
    • 2.9.2 Sinocare Major Business
    • 2.9.3 Sinocare Non-invasive Continuous Glucose Monitor Product and Services
    • 2.9.4 Sinocare Non-invasive Continuous Glucose Monitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Sinocare Recent Developments/Updates
  • 2.10 MicroTech Medical
    • 2.10.1 MicroTech Medical Details
    • 2.10.2 MicroTech Medical Major Business
    • 2.10.3 MicroTech Medical Non-invasive Continuous Glucose Monitor Product and Services
    • 2.10.4 MicroTech Medical Non-invasive Continuous Glucose Monitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 MicroTech Medical Recent Developments/Updates
  • 2.11 POCTech
    • 2.11.1 POCTech Details
    • 2.11.2 POCTech Major Business
    • 2.11.3 POCTech Non-invasive Continuous Glucose Monitor Product and Services
    • 2.11.4 POCTech Non-invasive Continuous Glucose Monitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 POCTech Recent Developments/Updates
  • 2.12 Medtrum Technologies
    • 2.12.1 Medtrum Technologies Details
    • 2.12.2 Medtrum Technologies Major Business
    • 2.12.3 Medtrum Technologies Non-invasive Continuous Glucose Monitor Product and Services
    • 2.12.4 Medtrum Technologies Non-invasive Continuous Glucose Monitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Medtrum Technologies Recent Developments/Updates
  • 2.13 SIBIONICS
    • 2.13.1 SIBIONICS Details
    • 2.13.2 SIBIONICS Major Business
    • 2.13.3 SIBIONICS Non-invasive Continuous Glucose Monitor Product and Services
    • 2.13.4 SIBIONICS Non-invasive Continuous Glucose Monitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 SIBIONICS Recent Developments/Updates

3 Competitive Environment: Non-invasive Continuous Glucose Monitor by Manufacturer

  • 3.1 Global Non-invasive Continuous Glucose Monitor Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Non-invasive Continuous Glucose Monitor Revenue by Manufacturer (2021-2026)
  • 3.3 Global Non-invasive Continuous Glucose Monitor Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Non-invasive Continuous Glucose Monitor by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Non-invasive Continuous Glucose Monitor Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Non-invasive Continuous Glucose Monitor Manufacturer Market Share in 2025
  • 3.5 Non-invasive Continuous Glucose Monitor Market: Overall Company Footprint Analysis
    • 3.5.1 Non-invasive Continuous Glucose Monitor Market: Region Footprint
    • 3.5.2 Non-invasive Continuous Glucose Monitor Market: Company Product Type Footprint
    • 3.5.3 Non-invasive Continuous Glucose Monitor Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Non-invasive Continuous Glucose Monitor Market Size by Region
    • 4.1.1 Global Non-invasive Continuous Glucose Monitor Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Non-invasive Continuous Glucose Monitor Consumption Value by Region (2021-2032)
    • 4.1.3 Global Non-invasive Continuous Glucose Monitor Average Price by Region (2021-2032)
  • 4.2 North America Non-invasive Continuous Glucose Monitor Consumption Value (2021-2032)
  • 4.3 Europe Non-invasive Continuous Glucose Monitor Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Non-invasive Continuous Glucose Monitor Consumption Value (2021-2032)
  • 4.5 South America Non-invasive Continuous Glucose Monitor Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Non-invasive Continuous Glucose Monitor Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Non-invasive Continuous Glucose Monitor Sales Quantity by Type (2021-2032)
  • 5.2 Global Non-invasive Continuous Glucose Monitor Consumption Value by Type (2021-2032)
  • 5.3 Global Non-invasive Continuous Glucose Monitor Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Non-invasive Continuous Glucose Monitor Sales Quantity by Application (2021-2032)
  • 6.2 Global Non-invasive Continuous Glucose Monitor Consumption Value by Application (2021-2032)
  • 6.3 Global Non-invasive Continuous Glucose Monitor Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Non-invasive Continuous Glucose Monitor Sales Quantity by Type (2021-2032)
  • 7.2 North America Non-invasive Continuous Glucose Monitor Sales Quantity by Application (2021-2032)
  • 7.3 North America Non-invasive Continuous Glucose Monitor Market Size by Country
    • 7.3.1 North America Non-invasive Continuous Glucose Monitor Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Non-invasive Continuous Glucose Monitor Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Non-invasive Continuous Glucose Monitor Sales Quantity by Type (2021-2032)
  • 8.2 Europe Non-invasive Continuous Glucose Monitor Sales Quantity by Application (2021-2032)
  • 8.3 Europe Non-invasive Continuous Glucose Monitor Market Size by Country
    • 8.3.1 Europe Non-invasive Continuous Glucose Monitor Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Non-invasive Continuous Glucose Monitor Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Non-invasive Continuous Glucose Monitor Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Non-invasive Continuous Glucose Monitor Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Non-invasive Continuous Glucose Monitor Market Size by Region
    • 9.3.1 Asia-Pacific Non-invasive Continuous Glucose Monitor Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Non-invasive Continuous Glucose Monitor Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Non-invasive Continuous Glucose Monitor Sales Quantity by Type (2021-2032)
  • 10.2 South America Non-invasive Continuous Glucose Monitor Sales Quantity by Application (2021-2032)
  • 10.3 South America Non-invasive Continuous Glucose Monitor Market Size by Country
    • 10.3.1 South America Non-invasive Continuous Glucose Monitor Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Non-invasive Continuous Glucose Monitor Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Non-invasive Continuous Glucose Monitor Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Non-invasive Continuous Glucose Monitor Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Non-invasive Continuous Glucose Monitor Market Size by Country
    • 11.3.1 Middle East & Africa Non-invasive Continuous Glucose Monitor Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Non-invasive Continuous Glucose Monitor Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Non-invasive Continuous Glucose Monitor Market Drivers
  • 12.2 Non-invasive Continuous Glucose Monitor Market Restraints
  • 12.3 Non-invasive Continuous Glucose Monitor Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Non-invasive Continuous Glucose Monitor and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Non-invasive Continuous Glucose Monitor
  • 13.3 Non-invasive Continuous Glucose Monitor Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Non-invasive Continuous Glucose Monitor Typical Distributors
  • 14.3 Non-invasive Continuous Glucose Monitor Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Non-invasive Continuous Glucose Monitor market size was valued at US$ 7240 million in 2025 and is forecast to a readjusted size of US$ 18895 million by 2032 with a CAGR of 14.8% during review period.
    Non-invasive Continuous Glucose Monitor is a glucose monitoring system that allows users to track glucose continuously without routine fingerstick blood sampling, avoiding the need to draw blood for day-to-day monitoring. It typically uses a wearable sensing component paired with durable electronics and software that collect signals frequently, estimate glucose levels and trends, and present results in a continuously updated view. These systems commonly provide alerts for rising or falling glucose and enable data sharing and longitudinal reporting, helping users and healthcare professionals manage therapy and reduce the risk of acute events and long-term complications. The unit price of a non-invasive continuous glucose monitor typically ranges from tens to hundreds of US dollars, with industry gross margins generally between 40% and 60%.
    Upstream, the supply chain is anchored by specialized inputs for the disposable sensing element such as sensing chemistry and materials, electrodes and substrates, membranes, adhesives and skin-contact components, microelectronics, batteries, and sterile packaging, alongside software capabilities for signal processing, calibration, analytics, and cybersecurity. Manufacturers then execute precision sensor fabrication, calibration and quality control, assembly of wearable form factors, production of durable components such as transmitters or integrated electronics, and development of mobile apps and cloud services under medical-grade quality systems, often supported by contract manufacturers for electronics assembly, packaging, and scaling. Downstream, products are commercialized through clinician-led initiation and training, pharmacy and medical device distribution for replenishment of disposable components, and direct-to-consumer channels where permitted, while reimbursement rules and procurement mechanisms heavily influence adoption and pricing. Downstream value is increasingly shaped by onboarding and education, customer support and replacement logistics, caregiver and clinician data-sharing features, and partnerships that integrate monitoring into telehealth, remote patient monitoring, and insulin management ecosystems that drive adherence and lifetime value.
    The non-invasive continuous glucose monitor market is evolving into a platform competition where long-term winners are determined less by the sensor patch itself and more by system reliability, alert performance, and ecosystem integration that supports real-world diabetes management. The key demand driver is the shift from episodic glucose checks to always-on monitoring that reduces uncertainty, supports behavioral change, and enables safer therapy decisions, especially for people who need tighter control or rapid feedback. Competitive advantage is increasingly built on the ability to deliver stable performance across daily conditions, minimize user burden through simple onboarding and durable wearability, and convert raw signals into trusted alerts and actionable insights. As the market expands beyond intensively managed users into broader populations, manufacturers face mounting expectations around clinical credibility, product quality, supply stability, and payer value demonstration, which collectively raise barriers to entry and favor scaled players with strong evidence generation and channel access.
    This report is a detailed and comprehensive analysis for global Non-invasive Continuous Glucose Monitor market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Non-invasive Continuous Glucose Monitor market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Non-invasive Continuous Glucose Monitor market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Non-invasive Continuous Glucose Monitor market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Non-invasive Continuous Glucose Monitor market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Non-invasive Continuous Glucose Monitor
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Non-invasive Continuous Glucose Monitor market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, Medtronic, Dexcom, I-SENS, 77 Elektronika, Senseonics, Yuwell, Sinocare, MicroTech Medical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Non-invasive Continuous Glucose Monitor market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Wristband Type
    Patch Type
    Others
    Market segment by Replacement Mechanism
    Replaceable Type
    Long-term Retention Type
    Market segment by Intelligence
    Basic Type
    Intelligent Type
    Market segment by Application
    Hospital
    Clinic
    Other
    Major players covered
    Roche
    Abbott
    Medtronic
    Dexcom
    I-SENS
    77 Elektronika
    Senseonics
    Yuwell
    Sinocare
    MicroTech Medical
    POCTech
    Medtrum Technologies
    SIBIONICS
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Non-invasive Continuous Glucose Monitor product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Non-invasive Continuous Glucose Monitor, with price, sales quantity, revenue, and global market share of Non-invasive Continuous Glucose Monitor from 2021 to 2026.
    Chapter 3, the Non-invasive Continuous Glucose Monitor competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Non-invasive Continuous Glucose Monitor breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Non-invasive Continuous Glucose Monitor market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Non-invasive Continuous Glucose Monitor.
    Chapter 14 and 15, to describe Non-invasive Continuous Glucose Monitor sales channel, distributors, customers, research findings and conclusion.

    Buy now